Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Caninized anti-NGF antibodies and methods thereof

Caninized anti-NGF antibodies and methods thereof

US Patent 9617334 · Granted Apr 11, 2017

Estimated economic value: $107,418,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids encoding canine anti-NGF antibodies and methods thereof2025
Anti-microbial articles2025
Method of determining the identity and/or amount of an anti-IL-31 antibody in a 2025
Anti-coronavirus vaccines2025
Interleukin-31 monoclonal antibodies for veterinary use2024
Methods of treating a canine and inhibiting NGF activity through use of anti-NGF2024
Humanized anti-NGF antibodies and methods of treating pain thereof2024
Felinized anti-NGF antibodies and methods of treating pain2024
Canine anti-NGF antibodies and methods of treating pain thereof2024
Nucleic acids encoding a canine antibody which binds nerve growth factor and vec2024
Interleukin-31 monoclonal antibodies for veterinary use2022
Peptide vaccines against interleukin-312022